Niraj Shah is a prominent inventor based in Owings Mills, MD (US), known for his significant contributions to the pharmaceutical industry. With a total of 10 patents to his name, he has made remarkable advancements in drug formulation and delivery systems.

Latest Patents

One of his latest patents involves the use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics. This patent discloses pharmaceutical compositions, particularly oral dosage forms, which comprise two or more enteric coating materials, either as a coating or as part of a matrix dosage form. The compositions are characterized by having a sustained release profile at lower pH and an accelerated dissolution profile at higher pH. Another notable patent is for once-daily formulations of tetracyclines, particularly doxycycline. These formulations are useful for treating collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, as well as acute and chronic inflammatory disease states, including rosacea and arthritis.

Career Highlights

Niraj Shah has worked with several reputable companies throughout his career, including Supernus Pharmaceuticals, Inc. and TCD Royalty Sub, LLC. His work in these organizations has contributed to the development of innovative pharmaceutical solutions that address various medical conditions.

Collaborations

Throughout his career, Shah has collaborated with talented individuals such as Rong-Kun Chang and Arash Raoufinia. These collaborations have further enhanced his ability to innovate and create effective pharmaceutical products.

Conclusion

Niraj Shah's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the industry positively, paving the way for advancements in drug delivery and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.